IP Library Granted Patent US 11,380,424
Granted Patent B2
US 11,380,424 · App. 16/674,189 · Granted Jul 5, 2022

System and method for genetic based efficacy testing

Inventors: Rob Todd (Doylestown, PA); Jerry Wrobel (Aurora, OH); John Pigott (Slyvania, OH)
Assignee: Xact Laboratories LLC
G16H10/40G16H10/60G16H15/00G16H20/10G16H50/70G16H70/40G16H80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,380,424
App. No.
16/674,189
Granted
Jul 5, 2022
Kind
B2
Abstract

System and methods for alerting a healthcare provider to prescribed treatments having reduced or no effectiveness due to genetic composition is provided. A database containing treatments known to have reduced or no efficacy in persons having particular genetic markers is queried to determine whether any treatments prescribed by, or likely to be prescribed by, a healthcare provider to the patient are known to have reduced or no efficacy in persons having the same genetic markers as the patient. An alert containing such information is displayed at a healthcare provider system.

Claims (23)

1. A system for providing genetic efficacy testing results to a number of users, the system comprising:

a number of user systems, each comprising medical records information, an electronic display, diagnostic codes indicating various diseases or conditions diagnosed by healthcare providers for patients, and treatment codes indicating various treatments prescribed by the healthcare providers to the patients;

a number of personal electronic device, each in electronic communication with at least one of said user systems;

a database comprising data regarding medications known to have reduced or no efficacy in persons having particular genetic markers;

a healthcare information exchange system (“HIE”) in electronic communication with each of the user systems;

a genetic sequencing machine; and

a laboratory system in electronic communication with the healthcare information exchange system, the database, and the genetic sequencing machine, wherein the laboratory system comprises a processor and an electronic storage device comprising software instructions, which when executed, configure the processor to:

receive the diagnostic codes and the treatment codes for a particular patient;

determine if tests for each of a number of genetic markers qualify as medically necessary based upon the diagnostic codes and the treatment codes received for the particular patient;

perform testing for each of the genetic markers qualifying as medically necessary;

receive testing results from the genetic sequencing machine indicating the presence or non-presence of each of the genetic markers tested;

query the database to determine whether any treatments associated with the treatment codes received are known to have reduced or no efficacy in persons having same ones of the genetic markers as those found to be present in the testing results; and

generate an alert comprising the treatments having reduced or no efficacy;

wherein said healthcare information exchange is configured to transmit the alert to at least the user systems associated with the healthcare provider ordering the tests and authorized to view the alert;

wherein the personal electronic devices associated with the user systems receiving the alerts are each configured to store and display said alert in an allergy portion of the user system.

2. The system of claim 1 wherein:

said database comprises a list of alternative treatment options; and

said laboratory system comprises additional software instructions stored at the electronic storage device, which when executed, configure the processor to determine alternative treatment options from the list of alternative treatment options stored at the database for each of the treatments having reduced or no efficacy.

3. The system of claim 2 wherein:

the treatments comprise medications; and

the alternative treatment options comprise other medications.

4. The system of claim 1 wherein:

the user systems authorized to view the alerts comprise user systems associated with a payor for the particular patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2020
From: TODD, ROB; WROBEL, JERRY; PIGOTT, JOHN
To: XACT LABORATORIES LLC
Reel/Frame 052484/0420 →
Continuity (4)
Continuation In Part 16441597 · Jun 14, 2019
Provisional Application 62773424 · Nov 30, 2018
Provisional Application 62685479 · Jun 15, 2018
Related Publication 20200075138A1 · Mar 5, 2020